The PHARMAC Board consists of up to 6 members – the Chair and up to 5 Directors – with a mix of skills and experience.
The Board has approved the PHARMAC Board Governance Manual providing an overview of the Board’s statutory duties and setting out the governance principles for the Board’s performance and conduct.
Stuart is a practicing Chartered Accountant specialising in business advisory and governance.
Stuart has been a partner for 30 years in the firm G S McLauchlan where he held the position of Managing Partner for 29 of those years. He is a fellow of the Institute of Chartered Accountants and an Accredited Fellow of the Institute of Directors.
He has a large portfolio of directorships in private, public and council owned companies as well as Government organisations. His current appointments include Chairman of Scott Technology, NZ Sports Hall of Fame, U.D.C Finance and Dunedin International Airport. Stuart is a Director of A D Instruments Pty Ltd, Aurora Energy Limited, Delta Utility Services Limited, Dunedin Casinos Ltd, Otago & Southland Employers Assn and Scenic Circle Hotels Ltd. Stuart is Pro-Chancellor of the University of Otago.
Stuart joined the PHARMAC Board in August 2009. His current membership expires on 31 July 2018.
Nicole Anderson (DipAcc, DipBus, DipMgt, PGDPH) is a consultant with a background in accountancy, health and business development.
She has worked primarily with organisations advancing Māori and Iwi, and with various public sector and private organisations, focusing on policy and commercial development.
A chartered member of the Institute of Directors (CMInstD), Nicole has been a member of various public and private sector governance bodies, including a member of the AUT University Council and Chair of the Council’s Maori Education Working Group, a Trustee of Hauora Hokianga Enterprise Trust, which governs the Rawene Hospital and associated health services, the Auckland Human Health & Disability Ethics Committee (Chair), the NRC Environment Committee and Northland Conservation Board.
Apart from her involvement in various whānau, hapū, Iwi and Māori organisations, she was the previous interim Project Manager for Tūhoronuku Independent Mandated Authority, the Ngāpuhi settlement entity.
Ko Ngāpuhi tōna iwi, nō Hokianga ia. Ka noho ia ki Kerikeri ki te taha o tōna whānau.
Nicole joined the PHARMAC Board in June 2014, and was reappointed for another 3 year term effective 13 June 2017.
Ross is a medical practitioner and Professor of Population Health, with a special interest in primary care and health services research.
Ross trained as a general practitioner in the UK and worked in Wairoa as a rural GP before going into health services management with the Waikato Area Health Board. He returned to the UK for a time as a senior lecturer and then Professor of Primary Health Care. His research centred on health outcomes research and pharmaco-epidemiology using large general practice databases. He has a particular interest in evidence-based medicine and has taught the principles of EBM at undergraduate and postgraduate levels.
He is a Fellow of the Royal College of General Practitioners, UK, Fellow of the Faculty of Public Health, UK and Fellow of the Australasian Faculty of Public Health Medicine. He was a Member of the GPRD International Advisory Group, Medicines and Healthcare products Regulatory Agency (MHRA) UK, and a non-executive for the Surrey and Sussex Strategic Health Authority. Since returning to New Zealand in 2005 he has been Deputy Chair of the New Zealand Guidelines Group, Chair of the National Screening Advisory Group, a board member of Pinnacle Group Ltd, board member of the NZ Rural General Practice Network, a member of the Ministry of Heath’s Prostate Taskforce and a member of the Ministry of Health Cancer Registry Board. As well as his role as Professor of Population Health with the University of Waikato, Ross is also the Clinical Director of Strategy and Funding for the Waikato District Health Board.
Ross was appointed to the Board for a 3-year term effective from 21 September 2016.
After more than 20 years as Chair/Chief Executive of large multinational enterprises in the health care industry in Europe and North America, Professor Mueller now consults with many firms around the globe on matters of governance and performance.
As Associate Professor for Entrepreneurship and Strategy for more than 15 years at the Waikato University Management School he works with MBA participants there, and has taught in Australia, Singapore, Germany, the Philippines, Cambodia and the USA with an emphasis on corporate performance strategies. Professor Mueller is a frequent author of academic articles, conference speaker, editor of several international refereed journals and co-editor/co-author of several books, including a best-selling book on Governance.
In New Zealand, Professor Mueller assists the Ministry of Health and the Minister with governance opportunities at District Health Boards and works with many companies and non-profit organisations to help create sustainable strategies based on strong governance structures.
Professor Mueller holds a Doctorate in Governance (PhD, Canterbury), a Doctorate in Law (JurDr, California), a Masters in Law (LLM, California), an MBA (MBA, Illinois) and a Masters in Advanced Management (MSAM, California).
Jens was appointed to the Board effective 1 July 2010. His term was extended for 3 years from 21 September 2016.
Jan (MBBS, MHP, FRACMA, FNZIM) is a medical practitioner who has worked in health management, strategy and policy for over 20 years.
Jan was trained in Australia and has worked in a number of institutions and organisations across the country. She came to New Zealand in 1999 to take up the position of Chief Executive of Health Waikato and, later, the Waikato District Health Board. Her most recent appointment was as Chief Executive of ACC which she left in 2011. She continues to consult, predominantly in the health sector, in both New Zealand and Australia. During her career, Jan has been a member of a wide range of governance bodies including Trusts, cooperative societies and subsidiaries of Crown Entities.
Jan was appointed to the PHARMAC Board in October 2012. Her current term expires 31 July 2018.
Last updated: 20 October 2017